EXOSURF NEONATAL (CETYL ALCOHOL; COLFOSCERIL PALMITATE; TY) — FDA Approval NDA020044 (GLAXOSMITHKLINE)
EXOSURF NEONATAL (CETYL ALCOHOL; COLFOSCERIL PALMITATE; TY) — FDA Approval NDA020044 (GLAXOSMITHKLINE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: EXOSURF NEONATAL; Active ingredients: CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL; Application number: NDA020044.
| Brand name | EXOSURF NEONATAL |
|---|---|
| Active ingredients | CETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL |
| Application number | NDA020044 |
| Sponsor | GLAXOSMITHKLINE |
| Dosage form | FOR SUSPENSION |
| Route | INTRATRACHEAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19900802 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →